tiprankstipranks
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
US Market

TriSalus Life Sciences (TLSI) Income Statement

Compare
39 Followers

TriSalus Life Sciences Income Statement

Last quarter (Q3 2024), TriSalus Life Sciences's total revenue was $7.35M, an increase of 41.52% from the same quarter last year. In Q3, TriSalus Life Sciences's net income was $-2.40M. See TriSalus Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 18.51M$ 12.40M$ 8.40M$ 5.43M
Gross Profit
$ 15.91M$ 10.14M$ 7.21M$ 3.24M
Operating Expenses
$ 70.06M$ 46.58M$ 31.24M$ 29.02M
Depreciation and Amortization
$ 702.00K$ 414.00K$ 464.00K$ 321.00K
EBITDA
$ -58.30M$ -46.76M$ -23.57M$ -25.32M
Operating Income
$ -54.15M$ -36.44M$ -24.03M$ -25.65M
Other Income/Expenses
$ -4.88M$ -10.74M$ -4.81M$ -6.18M
Pretax Income
$ -59.03M$ -47.18M$ -28.84M$ -31.83M
Net Income
$ -59.04M$ -47.19M$ -28.84M$ -31.83M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -6.73$ -1.59$ -0.92$ -1.04
Diluted EPS
$ -6.73$ -1.59$ -0.92$ -1.04
Weighted Average Shares Outstanding
9.40M 29.61M 31.25M 30.56M
Weighted Average Shares Outstanding (Diluted)
9.40M 29.61M 31.25M 30.56M
Currency in USD

TriSalus Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis